BlackRock Institutional Trust’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$40.5M Buy
912,651
+58,137
+7% +$2.58M 0.01% 1474
2016
Q3
$30.8M Buy
854,514
+31,478
+4% +$1.13M ﹤0.01% 1593
2016
Q2
$11.3M Sell
823,036
-2,049
-0.2% -$28.1K ﹤0.01% 2213
2016
Q1
$15.8M Buy
825,085
+54,476
+7% +$1.05M ﹤0.01% 1963
2015
Q4
$27M Buy
770,609
+14,029
+2% +$491K ﹤0.01% 1643
2015
Q3
$69.6M Buy
756,580
+65,779
+10% +$6.05M 0.01% 1040
2015
Q2
$60.7M Sell
690,801
-28,821
-4% -$2.53M 0.01% 1193
2015
Q1
$53.4M Buy
719,622
+3,902
+0.5% +$290K 0.01% 1278
2014
Q4
$40.1M Sell
715,720
-30,796
-4% -$1.72M 0.01% 1441
2014
Q3
$33.9M Sell
746,516
-18,217
-2% -$826K 0.01% 1527
2014
Q2
$31.7M Sell
764,733
-179,237
-19% -$7.42M 0.01% 1636
2014
Q1
$65.4M Buy
943,970
+300,508
+47% +$20.8M 0.01% 1118
2013
Q4
$38.8M Buy
643,462
+221,458
+52% +$13.3M 0.01% 1456
2013
Q3
$25.7M Buy
422,004
+155,870
+59% +$9.48M 0.01% 1673
2013
Q2
$17.8M Buy
+266,134
New +$17.8M ﹤0.01% 1887